开立医疗: 监事会关于公司2025年限制性股票与股票期权激励计划相关事项的核查意见

Group 1 - The company has confirmed that it meets the qualifications to implement the 2025 restricted stock and stock option incentive plan, as there are no disqualifying conditions outlined in relevant laws and regulations [1][2] - The incentive plan's designated recipients do not fall under any disqualifying conditions specified in the regulations, ensuring their eligibility [2] - The company will publicly disclose the names and positions of the incentive plan recipients for at least 10 days before the shareholders' meeting [3] Group 2 - The formulation and review process of the 2025 incentive plan comply with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [3] - There are no plans to provide loans, guarantees, or any financial assistance to the incentive recipients [4] - The implementation of the incentive plan is expected to enhance the company's incentive mechanism, attract and retain talent, and align the interests of shareholders, the company, and employees for long-term development [4]